Atherogenic lipoprotein phenotype: A proposed genetic marker for coronary heart disease risk

1.2kCitations
Citations of this article
215Readers
Mendeley users who have this article in their library.

Abstract

In a community-based study of 301 subjects from 61 nuclear families, two distinct phenotypes (denoted A and B) were identified by nondenaturing gradient gel electrophoretic analysis of low density lipoprotein (LDL) subclasses. Phenotype A was characterized by predominance of large, buoyant LDL particles, and phenotype B consisted of a major peak of small, dense LDL particles. Previous analysis of the family data by complex segregation analysis demonstrated that these phenotypes appear to be inherited as a single-gene trait. In the present study, the phenotypes were found to be closely associated with variations in plasma levels of other lipid, lipoprotein, and apolipoprotein measurements. Specifically, phenotype B was associated with increases in plasma levels of triglyceride and apolipoprotein B, with mass of very low and intermediate density lipoproteins, and with decreases in high density lipoprotein (HDL) cholesterol, HDL2 mass, and plasma levels of apolipoprotein A-I. Thus, the proposed genetic locus responsible for LDL subclass phenotypes also results in an atherogenic lipoprotein phenotype.

Cite

CITATION STYLE

APA

Austin, M. A., King, M. C., Vranizan, K. M., & Krauss, R. M. (1990). Atherogenic lipoprotein phenotype: A proposed genetic marker for coronary heart disease risk. Circulation, 82(2), 495–506. https://doi.org/10.1161/01.cir.82.2.495

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free